Leukemia Impact Factor, Indexing, Ranking

Leukemia (L) is a scholarly journal dedicated to publishing research in the field of Medicine. Nature Publishing is the publisher of this esteemed journal. The P-ISSN assigned to Leukemia is 0887-6924 and its abbreviated form is Leukemia.

Leukemia publishes high quality, peer reviewed research that covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.
Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more.
We publish a range of content types including original research articles, reviews, letters, correspondence and comments that elaborate on significant advances in the field and cover topical issues.

Leukemia Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Leukemia Journal is Leukemia.

The Ranking of Leukemia in 2026 is 500. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.

The Impact Factor of Leukemia in 2026 is 10.4. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors

The SCImago of Leukemia in 2026 is 3.376. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.

The H-Index of Leukemia in 2026 is 211. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.

The Quartile of Leukemia is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.

The Leukemia is indexed in (Indexing details)

• 1. Web of Science
• 2. Scopus
• 3. PubMed
• 4. Medline
• 5. Google Scholar

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.

The Editor-in-chief of Leukemia is Andreas Hochhaus, Germany

Leukemia Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of Leukemia is 3390 EUR

Leukemia Call for paper : Leukemia invites original research contributions for consideration of publication in Leukemia journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.

Publishing in Leukemia involves the following steps:

• Research: Conduct high-quality, impactful research in the field of Medicine.
• Familiarize Yourself: Read and understand the aims and scope of Leukemia to ensure your work aligns with their focus.
• Manuscript Preparation: Prepare your manuscript according to the Leukemia guidelines, including formatting, length, and referencing style.
• Submission: Submit your manuscript through the journal's online submission system.

• Journal Website
• PubMed
• Scopus
• SCImago